An innovative, quick and convenient labeling method for the investigation of pharmacological behavior and the metabolism of poly(DL-lactide-co-glycolide) nanospheres

Nanotechnology

Volumn 20, Issue 33, 2009, Pages

  Stevanović, Magdalena ^a   Maksin, Tatjana ^b   Petković, Jana ^c   Filipi, Metka ^c   Uskoković, Dragan ^a  

^a INSTITUTE OF TECHNICAL SCIENCES   (Serbia)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c NATIONAL INSTITUTE OF BIOLOGY   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACIDS; BIODISTRIBUTIONS; BLOOD CIRCULATION; HEPG2 CELLS; HOST RESPONSE; HUMAN HEPATOMA CELL LINES; IN-VITRO; LABELING METHODS; ORGANIC PHASIS; PHYSICOCHEMICAL METHODS; PLGA NANO-SPHERES; PLGA NANOPARTICLES; POLY(DL-LACTIDE-COGLYCOLIDE); SIZE RANGES; SOLVENT SYSTEM; STEREOLOGICAL ANALYSIS; TIME-DEPENDENT;

BIOCHEMISTRY; BIODEGRADATION; CARDIOVASCULAR SYSTEM; CELL CULTURE; CELL MEMBRANES; CHROMATOGRAPHIC ANALYSIS; KETONES; LABELING; METABOLISM; NANOPARTICLES; NANOSPHERES; ORGANIC ACIDS; PHOTODEGRADATION; SCANNING ELECTRON MICROSCOPY; TECHNETIUM; THIN LAYER CHROMATOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY;

X RAY DIFFRACTION ANALYSIS;

ASCORBIC ACID; NANOSPHERE; POLYGLACTIN; TECHNETIUM 99M; BUFFER; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; TECHNETIUM DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CIRCULATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG RELEASE; ENCAPSULATION; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VITRO STUDY; INTESTINE; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; SPLEEN; STOMACH; THIN LAYER CHROMATOGRAPHY; TRANSMISSION ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROSCOPY; X RAY DIFFRACTION; ANIMAL; CELL DEATH; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; KINETICS; METABOLISM; METHODOLOGY; STAINING; TIME; TISSUE DISTRIBUTION; TUMOR CELL LINE; ULTRASTRUCTURE; ULTRAVIOLET SPECTROPHOTOMETRY; WISTAR RAT;

ANIMALS; ASCORBIC ACID; BUFFERS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; KINETICS; LACTIC ACID; NANOSPHERES; POLYGLYCOLIC ACID; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ULTRAVIOLET; STAINING AND LABELING; TECHNETIUM COMPOUNDS; TIME FACTORS; TISSUE DISTRIBUTION; X-RAY DIFFRACTION;

EID: 70249129749     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/20/33/335102     Document Type: Article

References (61)

1. Hoffman A S 2008 The origins and evolution of 'controlled' drug delivery systems J. Control. Release 132 153-63
2. Sahoo S K, Parveen S and Panda J J 2007 The present and future of nanotechnology in human health care Nanomedicine 3 20-31
3. Kempen D H R, Lu L, Classic K L, Hefferan T E, Creemers L B, Maran A, Dhert W J A and Yaszemski M J 2008 Non-invasive screening method for simultaneous evaluation of in vivo growth factor release profiles from multiple ectopic bone tissue engineering implants J. Control. Release 130 15-21
4. Park J H, Lee S, Kim J H, Park K, Kim K and Kwon I C 2008 Polymeric nanomedicine for cancer therapy Prog. Polym. Sci. 33 113-37
5. Besenbache F, Sutherland D S and Hovgaard M B 2007 From nanoscience to nanotechnology: utilising the nanoscale Toxicol. Lett. 172 S34
6. Vasir J K, Reddy M K and Labhasetwar V D 2005 Nanosystems in drug targeting: opportunities and challenges Curr. Nanosci. 1 47-64
7. Kabanov A V and Gendelman H E 2007 Nanomedicine in the diagnosis and therapy of neurodegenerative disorders Prog. Polym. Sci. 32 1054-82
8. Chang J-Y, Yang C-H and Huang K-S 2007 Microfluidic assisted preparation of CdSe/ZnS nanocrystals encapsulated into poly(DL-lactide-co-glycolide) microcapsules Nanotechnology 18 305305
9. Moghimi S M, Hunter A C and Murray J C 2005 Nanomedicine: current status and future prospects FASEB J. 19 311-30
10. Sumer B and Gao J 2008 Theranostic nanomedicine for cancer Nanomedicine 3 137-40
11. Farokhzada O C and Langer R 2006 Nanomedicine: developing smarter therapeutic and diagnostic modalities Adv. Drug Deliv. Rev. 58 1456-9
12. Bae S E, Son J S, Park K and Han D K 2009 Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine J. Control. Release 133 37-43
13. Uhrich K E, Cannizzaro S M, Langer R S and Shakesheff K M 1999 Polymeric systems for controlled drug release Chem. Rev. 99 3181-98
14. Liu H and Webster T J 2007 Nanomedicine for implants: a review of studies and necessary experimental tools Biomaterials 28 354-69
15. Cohen-Sela E, Chorny M, Koroukhov N, Danenberg H D and Golomb G 2009 A new double emulsion solvent diffusion technique for encapsulating hydrophilic molecules in PLGA nanoparticles J. Control. Release 133 90-5
16. Mundargi R C, Babu V R, Rangaswamy V, Patel P and Aminabhavi T M 2008 Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives J. Control. Release 125 193-209
17. Stevanović M and Uskoković D 2009 Poly(lactide-co- glycolide)-based micro and nanoparticles for the controlled drug delivery of vitamins Curr. Nanosci. 5 1-14
18. Loher S, Reboul V, Brunner T J, Simonet M, Dora C, Neuenschwander P and Stark W J 2006 Improved degradation and bioactivity of amorphous aerosol derived tricalcium phosphate nanoparticles in poly(lactide-co-glycolide) Nanotechnology 17 2054-61
19. Pamula E and Menaszak E 2008 In vitro and in vivo degradation of poly(L-lactide-co-glycolide) films and scaffolds J. Mater. Sci. Mater. Med. 19 2063-70
20. Jevtić M, Mitrić M, kapin S, Janar B, Ignjatović N and Uskoković D 2008 Crystal structure of hydroxyapatite nano-rods synthesized by sonochemical homogenous precipitation Cryst. Growth Des. 8 2217-22
21. Jevtić M, Radulović A, Ignjatović N, Mitrić M and Uskoković D 2009 Controlled assembly of poly(D,L-lactide-co- glycolide)/hydroxyapatite core-shell nanospheres under ultrasonic irradiation Acta Biomater. 5 208-18
22. Hou Q, De Bank P A and Shakesheff K M 2004 Injectable scaffolds for tissue regeneration J. Mater. Chem. 14 1915-23
23. Ignjatović N L, Liu C Z, Czernuszka J T and Uskoković D P 2007 Micro- and nano-injectable composite biomaterials containing calcium phosphate coated with poly(dl-lactide-co-glycolide) Acta Biomater. 3 927-35
24. Miller R A, Brady J M and Cutright D E 1977 Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA/PGA copolymer ratios J. Biomed. Mater. Res. 11 711-9
25. O'Hogan D T, Rahman D, Mcgee J P, Jeffery H, Davies M C, Williams P, Davis S S and Challacombe S J 1991 Biodegradable microparticles as controlled release antigen delivery systems Immunology 73 239-42
26. Okada H and Toguchi H 1995 Biodegradable microspheres in drug delivery Crit. Rev. Ther. Drug. 12 1-99
27. Nair L S and Laurencin C T 2007 Biodegradable polymer as biomaterials Prog. Polym. Sci. 32 762-98
28. Mishima K 2008 Biodegradable particle formation for drug and gene delivery using supercritical fluid and dense gas Adv. Drug Deliv. Rev. 60 411-32
29. Gratton S E A, Pohlhaus P D, Lee J, Guo J, Cho M J and De Simone J M 2007 Nanofabricated particles for engineered drug therapies: a preliminary biodistribution study of PRINT™ nanoparticles J. Control. Release 121 10-8
30. Pareta R and Edirisinghe M J 2006 A novel method for the preparation of biodegradable microspheres for protein drug delivery J. R. Soc. Interface 3 573-82
31. Ahmad Z, Zhang H B, Farook U, Edirisinghe M, Stride E and Colombo P 2008 Generation of multilayered structures for biomedical applications using a novel tri-needle coaxial device and electrohydrodynamic flow J. R. Soc. Interface 5 1255-61
32. Mitranić I, Stevanović M, Nedeljković B, Ignjatović N and Uskoković D 2009 Controllable synthesis of horseradish peroxidase loaded poly(D,L-lactide) nanospheres J. Bionanosci. 3 1-11
33. Stevanović M, Radulović A, Jordović B and Uskoković D 2008 Poly(DL-lactide-co-glycolide) nanospheres for the sustained release of folic acid J. Biomed. Nanotechnol. 4 349-58
34. Stevanović M, Savić J, Jordović B and Uskoković D 2007 Fabrication, in vitro degradation and the release behaviours of poly(DL-lactide-co-glycolide) nanospheres containing ascorbic acid Colloids Surf. B 59 215-23
35. Zigoneanu I G, Astete C E and Sabliov C M 2008 Nanoparticles with entrapped α-tocopherol: synthesis, characterization, and controlled release Nanotechnology 19 105606
36. Yokoyama T and Huang C C 2005 Nanoparticle technology for the production of functional materials KONA 23 7-17
37. Smirnoff N 1996 The function and metabolism of ascorbic acid in plants Ann. Botany 78 661-9
38. Ratnam V, Ankola D D, Bhardwaj V, Sahana D K and Ravi Kumar M N V 2006 Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective J. Control. Release 113 189-207
39. Chen Q, Espey M G, Krishna M C, Mitchell J B, Corpe C P, Buettner G R, Shacter E and Levine M 2005 Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues Proc. Natl Acad. Sci. USA 102 13604-9
40. Lee Y S and Wurster R D 1994 Potentiation of anti-proliferative effect of nitroprusside by ascorbate in human brain tumor cells Cancer Lett. 78 19-23
41. Aidoo A, Lyn-Cook L E, Lensing S and Wamer W 1994 Ascorbic acid (vitamin C) modulates the mutagenic effects produced by an alkylating agent in vivo Environ. Mol. Mutagen. 24 220-8
42. Cameron E and Pauling L 1978 Supplemental ascorbate in the supportive treatment of cancer: reevaluation of prolongation of survival times in terminal human cancer Proc. Natl Acad. Sci. USA 75 4538-42
43. Austri R, Semenzato A and Bettero A 1997 Stability of vitamin C derivatives in solution and topical formulations J. Pharm. Biomed. Anal. 15 795-801
44. Spiclin P, Gasperlin M and Kmetec V 2001 Stability of ascorbyl palmitate in topical microemulsions Int. J. Pharm. 222 271-9
45. Gallarate M, Carlotti M E, Trotta M and Bovo S 1999 On the stability of ascorbic acid in emulsified systems for topical and cosmetic use Int. J. Pharm. 188 233-41
46. Yang J H, Lee S Y, Han Y S, Park K C and Choy J H 2003 Efficient transdermal penetration and improved stability of L-ascorbic acid encapsulated in an inorganic nanocapsule Bull. Korea Chem. Soc. 24 499-503
47. Semenzato A, Austria R, Dall'Aglio C and Bettero A 1995 HPLC determination of ionic compounds in cosmetic emulsions: application to magnesium ascorbyl phosphate J. Chromatogr. A 705 385-9
48. Chen B Y, Lee Y H, Lin W C, Lin F H and Lin K F 2006 Understanding the characteristics of L-ascorbic acid-montmorillonite nanocomposite: chemical structure and biotoxicity Biomed. Eng. Appl. Basis Commun. 18 30-6
49. Hansen T, Clermont G, Alves A, Eloy R, Brochhausen C, Boutrand J P, Gatti A M and Kirkpatrick1 C J 2006 Biological tolerance of different materials in bulk and nanoparticulate form in a rat model: sarcoma development by nanoparticles J. R. Soc. Interface 3 767-75
50. Mosman T 1983 Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays J. Immunol. Methods 65 55-63
51. Maksin T, Dokić D, Janković D, Dordević A and Neković O 2007 Comparison of some physico-chemical parameters and biological behaviour of fullerenol labeled with technetium-99m J. Optoelectron. Adv. M. 9 2571-7
52. x and its biodistribution studies Nucl. Med. Biol. 29 707-10
53. x in Sprague-Dawley rats after intratracheal installation Carbon 45 1865-70
54. 99mTc-DMSA J. Radioanal. Nucl. Chem. 141 91-9
55. Halder K K, Mandal B, Debnath M C, Bera H G, Hosh L K and Gupta B K 2008 Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies J. Drug Target. 16 311-20
56. Snehalatha M, Venugopal K, Saha R N, Babbar A K and Sharma R K 2008 Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99m Drug Deliv. 15 277-87
57. ICDD file No. 04-0308 (Ascorbic acid), Powder diffraction files, International Center for Diffraction Data
58. Knasmüller S et al 1998 Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens Mutat. Res. 402 185-202
59. egura B, Lah T T and Filipi M 2004 The role of reactive oxygen species in microcystin-LR-induced DNA damage Toxicology 200 59-68
60. Plazar J, egura B, Lah T T and Filipi M 2007 Protective effects of xanthohumol against the genotoxicity of benzo(a)pyrene(BaP), 2-amino-3-methylimidazo[4,5-f] quinoline (IQ) and tert-butylhydroperoxide (t-BOOH) in HepG2 human hepatoma cells Mutat. Res. 632 1-8
61. Hreljac I, Zajc I, Lah T and Filipi M 2008 Effects of model organophosphorous pesticides on DNA damage and proliferation of HepG2 cells Environ. Mol. Mutagen. 49 360-7